Wall Street analysts expect Simulations Plus, Inc. (NASDAQ:SLP) to announce $12.93 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Simulations Plus’ earnings, with the highest sales estimate coming in at $13.50 million and the lowest estimate coming in at $12.36 million. Simulations Plus posted sales of $10.35 million during the same quarter last year, which suggests a positive year-over-year growth rate of 24.9%. The business is expected to issue its next earnings results after the market closes on Monday, April 12th.
On average, analysts expect that Simulations Plus will report full year sales of $50.77 million for the current year, with estimates ranging from $50.66 million to $50.88 million. For the next fiscal year, analysts anticipate that the firm will report sales of $59.85 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover Simulations Plus.
Simulations Plus (NASDAQ:SLP) last issued its earnings results on Sunday, January 10th. The technology company reported $0.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.01. The business had revenue of $10.70 million during the quarter, compared to analysts’ expectations of $10.56 million. Simulations Plus had a return on equity of 10.65% and a net margin of 22.74%.
SLP has been the subject of several recent research reports. TheStreet upgraded Simulations Plus from a “c+” rating to a “b” rating in a report on Friday, January 8th. Craig Hallum lowered Simulations Plus from a “buy” rating to a “hold” rating in a report on Tuesday, January 12th. Oppenheimer increased their price objective on Simulations Plus from $79.00 to $85.00 in a report on Tuesday, January 12th. Finally, Zacks Investment Research upgraded Simulations Plus from a “sell” rating to a “hold” rating in a report on Wednesday, January 13th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Simulations Plus has an average rating of “Buy” and a consensus target price of $81.60.
Shares of Simulations Plus stock traded down $0.20 during midday trading on Monday, hitting $63.78. The company’s stock had a trading volume of 2,416 shares, compared to its average volume of 210,740. The firm has a market capitalization of $1.27 billion, a P/E ratio of 125.45, a PEG ratio of 8.45 and a beta of -0.07. The stock has a 50-day simple moving average of $67.89 and a 200-day simple moving average of $69.71. Simulations Plus has a 1-year low of $32.18 and a 1-year high of $90.92.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 1st. Stockholders of record on Monday, January 25th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, January 22nd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.38%. Simulations Plus’s payout ratio is presently 42.86%.
In other news, Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction dated Thursday, March 25th. The stock was sold at an average price of $60.04, for a total value of $1,440,960.00. Also, insider John Anthony Dibella II sold 2,360 shares of Simulations Plus stock in a transaction dated Wednesday, January 27th. The stock was sold at an average price of $80.00, for a total value of $188,800.00. Following the completion of the transaction, the insider now owns 44,840 shares in the company, valued at $3,587,200. The disclosure for this sale can be found here. Insiders sold 96,870 shares of company stock worth $7,001,958 over the last quarter. 24.45% of the stock is currently owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the stock. First Trust Advisors LP acquired a new stake in Simulations Plus during the fourth quarter worth about $2,790,000. Mountain Capital Investment Advisors Inc acquired a new stake in Simulations Plus during the fourth quarter valued at approximately $586,000. Vantage Consulting Group Inc acquired a new stake in Simulations Plus during the fourth quarter valued at approximately $53,000. Oregon Public Employees Retirement Fund boosted its holdings in Simulations Plus by 22.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,015 shares of the technology company’s stock valued at $433,000 after purchasing an additional 1,105 shares in the last quarter. Finally, Cim Investment Mangement Inc. acquired a new stake in Simulations Plus during the third quarter valued at approximately $312,000. 60.75% of the stock is currently owned by institutional investors and hedge funds.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments.
Recommended Story: What is a recession?
For more information about research offerings from Zacks Investment Research, visit Zacks.com